These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 22273664

  • 1. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
    Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D.
    Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, Nabeshima K, Nakai S, Kato M, Ohashi A, Arai J, Hiki Y, Ishii J, Emi N, Sugiyama S, Yuzawa Y.
    Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Extended high cut-off haemodialysis for myeloma cast nephropathy in Auckland, 2008-2012.
    Tan J, Lam-Po-Tang M, Hutchison CA, de Zoysa JR.
    Nephrology (Carlton); 2014 Jul; 19(7):432-5. PubMed ID: 24931113
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Successful use of combined high cut-off haemodialysis and bortezomib for acute kidney injury associated with myeloma cast nephropathy.
    Ward F, Dunne O, Crotty TB, Fennelly D, Watson A, Holian J.
    Ir Med J; 2012 May; 105(5):148-9. PubMed ID: 22803494
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
    Cockwell P, Cook M.
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):324-32. PubMed ID: 22920643
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effectiveness of haemodiafiltration with ultrafiltrate regeneration in the reduction of light chains in multiple myeloma with renal failure.
    Pendón-Ruiz de Mier MV, Alvarez-Lara MA, Ojeda-López R, Martín-Malo A, Carracedo J, Caballero-Villarraso J, Alonso C, Aljama P.
    Nefrologia; 2013 Nov 13; 33(6):788-96. PubMed ID: 24241366
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
    Rousseau-Gagnon M, Agharazii M, De Serres SA, Desmeules S.
    PLoS One; 2015 Nov 13; 10(10):e0140463. PubMed ID: 26466100
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.
    Hutchison CA, Cockwell P, Moroz V, Bradwell AR, Fifer L, Gillmore JD, Jesky MD, Storr M, Wessels J, Winearls CG, Weisel K, Heyne N, Cook M.
    Lancet Haematol; 2019 Apr 13; 6(4):e217-e228. PubMed ID: 30872075
    [Abstract] [Full Text] [Related]

  • 14. Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: preliminary quantitative study.
    Granger Vallée A, Chenine L, Leray-Moragues H, Patrier L, Cognot C, Cartron G, Cristol JP, Canaud B.
    Nephrol Dial Transplant; 2011 Nov 13; 26(11):3627-33. PubMed ID: 21508098
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series.
    Menè P, Giammarioli E, Fofi C, Antolino G, Verde G, Tafuri A, Punzo G, Festuccia F.
    Kidney Blood Press Res; 2018 Nov 13; 43(4):1263-1272. PubMed ID: 30078004
    [Abstract] [Full Text] [Related]

  • 18. Myeloma kidney: improving clinical outcomes?
    Haynes R, Leung N, Kyle R, Winearls CG.
    Adv Chronic Kidney Dis; 2012 Sep 13; 19(5):342-51. PubMed ID: 22920645
    [Abstract] [Full Text] [Related]

  • 19. Extracorporeal treatment of cast nephropathy.
    Gakhar B, Kobrin S, Berns JS.
    Semin Dial; 2011 Sep 13; 24(1):9-11. PubMed ID: 21324000
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.